Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys

Psychopharmacology

Volumn 198, Issue 4, 2008, Pages 521-528

  Delatte, Marcus S ^a   Paronis, Carol A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anxiolytic; Benzodiazepine; Cannabinoids; Drug discrimination; Monkey; Operant; Punished responding

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; DRONABINOL; MIDAZOLAM; PENTOBARBITAL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG EFFECT; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PUNISHMENT; REINFORCEMENT; TRAINING;

ANIMALS; BENZOXAZINES; CANNABINOIDS; DATA INTERPRETATION, STATISTICAL; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD; GAMMA-AMINOBUTYRIC ACID; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; MORPHOLINES; NAPHTHALENES; PUNISHMENT; RECEPTOR, CANNABINOID, CB1; SAIMIRI; TETRAHYDROCANNABINOL;

EID: 44449091593     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0918-5     Document Type: Article

References (39)

1. Ator NA (2002) Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons. Psychopharmacology (Berl) 163:477-487
2. Barrett JE, Brady LS, Witkin JM (1985) Behavioral studies with anxiolytic drugs. I. Interactions of the benzodiazepine antagonist Ro 15-1788 with chlordiazepoxide, pentobarbital and ethanol. J Pharmacol Exp Ther 233:554-559
3. Barrett RL, Wiley JL, Balster RL, Martin BR (1995) Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology (Berl) 118:419-424
4. Benvenga MJ, Leander JD (1996) Anticonflict effects of 5HT(1A) agonists in pigeons are dependent on the level of response suppression. Behav Pharmacol 7:540-550
5. Delatte MS, Winsauer PJ, Moerschbaecher JM (2002) Tolerance to the disruptive effects of Delta(9)-THC on learning in rats. Pharmacol Biochem Behav 74:129-140
6. Evans S, Johanson C (1988) The discriminative stimulus properties of midazolam in pigeons. NIDA Res Monogr 81:115-121
7. Fabre LF, McLendon D (1981) The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. J Clin Pharmacol 21:377S-382S
8. Ferraro DP, Grilly DM (1974) Effects of chronic exposure to delta9-tetrahydrocannabinol on delayed matching-to-sample in chimpanzees. Psychopharmacologia 37:127-138
9. Garcha HS, Rose IC, Stolerman IP (1985) Midazolam cue in rats: generalization tests with anxiolytic and other drugs. Psychopharmacology (Berl) 87:233-237
10. Glass RM, Uhlenhuth EH, Hartel FW, Schuster CR, Fischman MW (1981) Single-dose study of nabilone in anxious volunteers. J Clin Pharmacol 21:383S-396S
11. Gold LH, Balster RL, Barrett RL, Britt DT, Martin BR (1992) A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys. J Pharmacol Exp Ther 262:479-486
12. Ilaria RL, Thornby JI, Fann WE (2001) Nabilone, a cannabinoid derivative, in the treatment of anxiety neuroses. Curr Ther Res 29:943-949
13. Järbe TU, Hiltunen AJ (1988) Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils. Psychopharmacology (Berl) 94:328-331
14. Järbe TU, Ohlin GC (1979) Discriminative effects of combinations of delta 9-tetrahydrocannabinol and pentobarbital in pigeons. Psychopharmacology (Berl) 63:233-239
15. Järbe TU, Johansson JO, Henriksson BG (1975) Delta9- tetrahydrocannabinol and pentobarbital as discriminative cues in the Mongolian Gerbil (Meriones unguiculatus). Pharmacol Biochem Behav 3:403-410
16. Kosersky DS, McMillan DE, Harris LS (1974) Delta9-tetrahydrocannabinol and 11-hydroxy-delta9-tetrahydrocannabinol: behavioral effects and tolerance development. J Pharmacol Exp Ther 189:61-65
17. Lelas S, Gerak LR, France CP (1999) Discriminative-stimulus effects of triazolam and midazolam in rhesus monkeys. Behav Pharmacol 10:39-50
18. Margules DL, Stein L (1968) Increase of "antianxiety" activity and tolerance of behavioral depression during chronic administration of oxazepam. Psychopharmacologia 13:74-80
19. McMahon LR, France CP (2005) Combined discriminative stimulus effects of midazolam with other positive GABAA modulators and GABAA receptor agonists in rhesus monkeys. Psychopharmacology (Berl) 178:400-409
20. McMahon LR, Amin MR, France CP (2005) SR 141716A differentially attenuates the behavioral effects of delta9-THC in rhesus monkeys. Behav Pharmacol 16:363-372
21. McMillan DE (1973) Drugs and punished responding. I. Rate-dependent effects under multiple schedules. J Exp Anal Behav 19:133-145
22. McMillan DE, Leander JD (1978) Chronic chlordiazepoxide and pentobarbital interactions on punished and unpunished behavior. J Pharmacol Exp Ther 207:515-520
23. Mokler DJ, Nelson BD, Harris LS, Rosecrans JA (1986) The role of benzodiazepine receptors in the discriminative stimulus properties of delta-9-tetrahydrocannabinol. Life Sci 38:1581-1589
24. Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253:1002-1009
25. Orr LE, McKernan JF (1981) Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine. J Clin Pharmacol 21:76S-80S
26. Petitet F, Jeantaud B, Reibaud M, Imperato A, Dubroeucq MC (1998) Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci 63:L1-L6
27. Robson P (2001) Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry 178:107-115
28. Sepinwall J, Grodsky FS, Cook L (1978) Conflict behavior in the squirrel monkey: effects of chlordiazepoxide, diazepam and N-desmethyldiazepam. J Pharmacol Exp Ther 204:88-102
29. Shen M, Thayer SA (1999) Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol Pharmacol 55:8-13
30. Shumsky JS, Lucki I (1996) Differential tolerance to the effects of chlordiazepoxide on unpunished and punished operant responding following chronic treatment. Pharmacol Biochem Behav 53:593-601
31. Spealman RD (1985) Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by Ro 15-1788. J Pharmacol Exp Ther 235:456-462
32. Spealman RD, Goldberg SR, Kelleher RT, Goldberg DM, Charlton JP (1977) Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 202:500-509
33. Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG (2007) Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol 150:613-623
34. Tidey JW, Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163-1174
35. Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323:16-21
36. Wiley JL, Martin BR (1999) Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination. Pharmacol Biochem Behav 64:519-522
37. Wiley JL, Huffman JW, Balster RL, Martin BR (1995) Pharmacological specificity of the discriminative stimulus effects of delta 9- tetrahydrocannabinol in rhesus monkeys. Drug Alcohol Depend 40:81-86
38. Witkin JM, Barrett JE (1981) Effects of pentobarbital on punished behavior: persistent increases with chronic administration. Psychopharmacology (Berl) 75:324-325
39. Witkin JM, Tzavara ET, Nomikos GG (2005) A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behav Pharmacol 16:315-331